In the case of chRCC, the expression levels of Ki-67, CD44, MMP-2, and MMP-9 were not associated with gender and patient age, tumor size, and tumor necrosis (p > 0.05, Kendall’s rank coefficient). The gene discussed is CD44; the disease is chromophobe renal cell carcinoma.